Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1424 NOK | -1.66% | -5.32% | -48.78% |
Sales 2023 | 354K 32.55K | Sales 2024 * | - | Capitalization | 557M 51.19M |
---|---|---|---|---|---|
Net income 2023 | -190M -17.47M | Net income 2024 * | -195M -17.93M | EV / Sales 2023 | 1,670 x |
Net cash position 2023 | 156M 14.38M | Net Debt 2024 * | 70.86M 6.52M | EV / Sales 2024 * | - |
P/E ratio 2023 |
-2.14
x | P/E ratio 2024 * |
-1.97
x | Employees | 25 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 91.97% |
Latest transcript on BerGenBio ASA
1 day | -1.66% | ||
1 week | -8.72% | ||
Current month | -1.79% | ||
1 month | -21.06% | ||
3 months | -47.26% | ||
6 months | -30.71% | ||
Current year | -48.78% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Olin
CEO | Chief Executive Officer | 55 | 21-09-07 |
Rune Skeie
DFI | Director of Finance/CFO | 51 | 18-03-04 |
Nigel McCracken
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sally Bennett
BRD | Director/Board Member | 52 | 20-12-08 |
Sveinung Hole
BRD | Director/Board Member | 57 | 10-08-31 |
Chairman | 63 | 22-01-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.1424 | -1.66% | 29,712,340 |
24-05-02 | 0.1448 | -0.14% | 49,776,390 |
24-04-30 | 0.145 | -2.42% | 28,906,750 |
24-04-29 | 0.1486 | -1.20% | 26,594,580 |
24-04-26 | 0.1504 | -3.59% | 87,228,100 |
Real-time Oslo Bors, May 03, 2024 at 10:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.78% | 51.23M | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- BGBIO Stock